Ledger.Open graph →
SEC Form D · filed August 18, 2021

Venn Biosciences Corp

Offering
$201.3M
Sold
$173.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Michael · SOUTH SAN FRANCISCO, CADirectorAldo Carrascoso · SOUTH SAN FRANCISCO, CAExec · DirectorJenny Rooke · SOUTH SAN FRANCISCO, CADirectorMatthew Walsh · BROOKLYN, NYExec · DirectorHadi Taheri · San Francisco, CADirectorAlice Nawfal · BROOKLYN, NYDirectorNathan Brown · Grand Duchy of Luxembourg, LuxembourgDirectorHille-Paul Schut · Grand Duchy of Luxembourg, LuxembourgDirectorRitchie Deffenbaugh · Argyle, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗